gaucher disease type 1
Showing 1 - 6 of 6
Gaucher Disease Type 1 Trial in Jerusalem (Enzyme replacement therapy for Gaucher disease in combination with altus care
Completed
- Gaucher Disease Type 1
- Enzyme replacement therapy for Gaucher disease in combination with altus care application
-
Jerusalem, IsraelHebrew university
Sep 18, 2023
Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Worldwide (venglustat (GZ402671), imiglucerase)
Active, not recruiting
- Gaucher Disease Type 1
- Gaucher Disease Type 3
- venglustat (GZ402671)
- imiglucerase
-
New Haven, Connecticut
- +6 more
Aug 9, 2022
Bone Pathology in Patients With Type 1 Gaucher Disease
Unknown status
- Gaucher Disease Type 1
-
Fairfax, VirginiaLDRTC
Aug 13, 2019
Gaucher Disease Type 1 Trial in Worldwide (Miglustat)
Completed
- Gaucher Disease Type 1
-
San Francisco, California
- +19 more
Oct 24, 2018
Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Dallas (Velaglucerase alfa)
Withdrawn
- Gaucher Disease Type 1
- Gaucher Disease Type 3
- Velaglucerase alfa
-
Dallas, TexasBaylor Research Institute
Feb 28, 2018
Gaucher Disease Type 1 Trial in Jerusalem (BeamMed Speed-of-Sound bone strength test at forearm)
Completed
- Gaucher Disease Type 1
- BeamMed Speed-of-Sound bone strength test at forearm
-
Jerusalem, IsraelShaare Zedek Medical Center
Nov 18, 2014